Paper · 24976009
YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response.
Azzolin L and 12 others. Cell, 2014. Cited by 946 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response. Papers, record 24976009. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24976009
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adaptor Proteins, Signal Transducing | Major topic |
| Phosphoproteins | Major topic |
| Transcription Factors | Major topic |
| Wnt Proteins | Major topic |
| beta Catenin | Major topic |
| Acyltransferases | |
| Animals | |
| Cell Cycle Proteins | |
| Cell Line | |
| Embryonic Stem Cells | |
| HEK293 Cells | |
| Humans | |
| Mice | |
| Models, Biological | |
| YAP-Signaling Proteins |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by705
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 946 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,873,329 | Hippo-YAP/TAZ signalling at the crossroads of brain ageing and neurological disorders: mechanisms, crosstalk, and therapeutic prospects. | Biogerontology | 2026 | https://conductscience.org/library/papers/42873329 | PubMed |
| 42,859,149 | Canonical Wnt signaling in the regulation of prostate cancer stem cells: a key driver of castration-resistant prostate cancer and a therapeutic opportunity. | J Transl Med | 2026 | https://conductscience.org/library/papers/42859149 | PubMed |
| 42,757,476 | E3 ubiquitin ligase MAGI3‑mediated TAZ ubiquitination suppresses the non‑small cell lung cancer occurrence and development by targeting the Wnt pathway. | Int J Oncol | 2026 | https://conductscience.org/library/papers/42757476 | PubMed |
| 42,650,044 | Linking EMT Dynamics to Cellular Plasticity: YAP/TAZ as Central Regulators Across Physiological and Pathological States. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42650044 | PubMed |
| 42,635,265 | Biophysics of lumen morphogenesis. | Development | 2026 | https://conductscience.org/library/papers/42635265 | PubMed |
| 42,620,708 | Early targeting of the YAP/TEAD-PKC-NF-κB axis alleviates post-traumatic osteoarthritis. | iScience | 2026 | https://conductscience.org/library/papers/42620708 | PubMed |
| 42,593,641 | RNA methyltransferase NSUN5 promotes oral squamous cell carcinoma proliferation and migration by enhancing YAP1 expression in an m5C-dependent manner. | Odontology | 2026 | https://conductscience.org/library/papers/42593641 | PubMed |
| 42,589,304 | A Convergence Model of Bioelectric, Gap Junctional, and Hippo-YAP Signalling in Oral Cancer Stem Cell Maintenance. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589304 | PubMed |
| 42,587,804 | Current Status of Intestinal Stem Cell Research: Mechanisms, Intestinal Diseases, and Organoid Development. | Cells | 2026 | https://conductscience.org/library/papers/42587804 | PubMed |
| 42,558,868 | Rewired DDR-TGF-β-β-catenin-PD-L1 axis accelerates progression and shapes therapy in human papillomavirus-driven cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42558868 | PubMed |
1 to 10 of 705
See all 705 cited byGenes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AXIN1 | 8,312 | PubTator's text mining | https://conductscience.org/library/genes/8312 | NCBI Gene |
| BTRC | 8,945 | PubTator's text mining | https://conductscience.org/library/genes/8945 | NCBI Gene |
| CTNNB1 | 1,499 | PubTator's text mining | https://conductscience.org/library/genes/1499 | NCBI Gene |
| GSK3B | 2,932 | PubTator's text mining | https://conductscience.org/library/genes/2932 | NCBI Gene |
| TAFAZZIN | 6,901 | PubTator's text mining | https://conductscience.org/library/genes/6901 | NCBI Gene |
| YAP1 | 10,413 | PubTator's text mining | https://conductscience.org/library/genes/10413 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24976009
GET https://conductscience.org/api/papers/v1/24976009/cited_by?page=2